TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
21 hedge funds and large institutions have $371K invested in Titan Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
21
Holding in Top 10
–
Calls
$21K
Puts
–
Top Buyers
| 1 | +$107K | |
| 2 | +$94.3K | |
| 3 | +$62K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$35K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.78K |
Top Sellers
| 1 | -$83K | |
| 2 | -$22K | |
| 3 | -$5K | |
| 4 |
Goldman Sachs
New York
|
-$3K |
| 5 |
WPA
Winning Points Advisors
Boca Raton,
Florida
|
-$3K |